Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07510074 · ClinicalTrials.gov registry record · NA
Modulating Inflammation in Neuro-Trauma
A NA study, sponsored by The University of Texas Health Science Center at San Antonio.
- Not yet
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT07510074 is a NA study that has not yet begun recruiting, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 16 participants.
The verdict
NCT07510074, a NA study, has not yet begun recruiting, sponsored by The University of Texas Health Science Center at San Antonio.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
MINT is a single-site, prospective, randomized, double-blind, sham-controlled pilot trial evaluating the safety and feasibility of transcutaneous auricular vagus nerve stimulation (taVNS) in patients with moderate to severe traumatic brain injury (GCS 3-12). Participants will be randomized to receive either active taVNS or sham stimulation using the same device. The primary objective is to assess the safety and feasibility of taVNS implementation in the acute TBI setting. Secondary objectives include exploratory measurement of serum inflammatory and neuronal injury biomarkers and assessment of functional outcome using the Extended Glasgow Outcome Scale at hospital discharge.
Interventions
- DEVICE Nurosym taVNS
- DEVICE Nurosym (sham)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2026-05 |
| Est. Completion | 2027-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07510074
The ClinicalTrials.gov registry entry for NCT07510074 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nurosym taVNS is the first listed.
NCT07510074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07510074 about?
NCT07510074 is a clinical study titled "Modulating Inflammation in Neuro-Trauma". MINT is a single-site, prospective, randomized, double-blind, sham-controlled pilot trial evaluating the safety and feasibility of transcutaneous auricular vagus nerve stimulation (taVNS) in patients with moderate to severe traumatic brain injury (GCS 3-12). Participants will be randomized to receiv...
What is the current status of trial NCT07510074?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2026-05. Estimated completion is 2027-03.
What interventions are being tested in trial NCT07510074?
The interventions under investigation include: Nurosym taVNS (DEVICE), Nurosym (sham) (DEVICE).
Who is sponsoring clinical trial NCT07510074?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.